Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)

Fig. 2

a Morning home systolic blood pressure (SBP), b morning home diastolic blood pressure (DBP), c evening home SBP, d evening home DBP, e nocturnal home SBP, and f nocturnal home DBP at baseline and after 24 weeks of add-on dapagliflozin treatment (week 24). The change from baseline to week 24 was analyzed using a one-sided paired t-test. *P < 0.05, **P < 0.01, ****P < 0.001

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840